Nothing Special   »   [go: up one dir, main page]

CN105948086B - Citric acid pillared hydrotalcite supramolecular materials and its intercalation assemble method - Google Patents

Citric acid pillared hydrotalcite supramolecular materials and its intercalation assemble method Download PDF

Info

Publication number
CN105948086B
CN105948086B CN201610368501.4A CN201610368501A CN105948086B CN 105948086 B CN105948086 B CN 105948086B CN 201610368501 A CN201610368501 A CN 201610368501A CN 105948086 B CN105948086 B CN 105948086B
Authority
CN
China
Prior art keywords
citric acid
ldhs
hydrotalcite
pillared
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201610368501.4A
Other languages
Chinese (zh)
Other versions
CN105948086A (en
Inventor
彭霞辉
刘琳琪
赵晨曦
王小梅
吴天泉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Changsha University
Original Assignee
Changsha University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Changsha University filed Critical Changsha University
Priority to CN201610368501.4A priority Critical patent/CN105948086B/en
Publication of CN105948086A publication Critical patent/CN105948086A/en
Application granted granted Critical
Publication of CN105948086B publication Critical patent/CN105948086B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01FCOMPOUNDS OF THE METALS BERYLLIUM, MAGNESIUM, ALUMINIUM, CALCIUM, STRONTIUM, BARIUM, RADIUM, THORIUM, OR OF THE RARE-EARTH METALS
    • C01F7/00Compounds of aluminium
    • C01F7/78Compounds containing aluminium and two or more other elements, with the exception of oxygen and hydrogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01PINDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2002/00Crystal-structural characteristics
    • C01P2002/20Two-dimensional structures
    • C01P2002/22Two-dimensional structures layered hydroxide-type, e.g. of the hydrotalcite-type
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01PINDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2002/00Crystal-structural characteristics
    • C01P2002/70Crystal-structural characteristics defined by measured X-ray, neutron or electron diffraction data
    • C01P2002/72Crystal-structural characteristics defined by measured X-ray, neutron or electron diffraction data by d-values or two theta-values, e.g. as X-ray diagram
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01PINDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2002/00Crystal-structural characteristics
    • C01P2002/80Crystal-structural characteristics defined by measured data other than those specified in group C01P2002/70
    • C01P2002/82Crystal-structural characteristics defined by measured data other than those specified in group C01P2002/70 by IR- or Raman-data
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01PINDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2002/00Crystal-structural characteristics
    • C01P2002/80Crystal-structural characteristics defined by measured data other than those specified in group C01P2002/70
    • C01P2002/88Crystal-structural characteristics defined by measured data other than those specified in group C01P2002/70 by thermal analysis data, e.g. TGA, DTA, DSC

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Geology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention discloses a kind of citric acid pillared hydrotalcite supramolecular materials and its intercalation assemble method, belong to supramolecular materials technical field, with CO3 2‑Magnalium hydrotalcite is precursor, and citric acid pillared hydrotalcite is successfully prepared for the back-mixing precipitation method.Pass through X-ray powder diffraction (XRD), infrared spectrum analysis (IR), three kinds of methods of differential thermal analysis (DTA) are characterized and determined to crystal structure, chemical constitution and the heat endurance of prepared citric acid pillared hydrotalcite;Interfloor distance expands, i.e., intercalation assembles successfully citric acid, and with individual layer, perpendicular acting in interlayer;The drug release rate of citric acid pillared hydrotalcite determines under the conditions of pH3.6 acetate buffer, as a result the reduction of citric acid pillared hydrotalcite rate of release is shown, with slow releasing function, illustrate that citric acid-inorganic mixture material can act as effective drug delivery system.

Description

Citric acid pillared hydrotalcite supramolecular materials and its intercalation assemble method
Technical field
The invention belongs to supramolecular materials technical field, is related to a kind of citric acid pillared hydrotalcite supramolecular materials and its inserts Layer assemble method.
Background technology
Hydrotalcite (Layered Double Hydroxides, abbreviation LDHs) formula is [M2+ 1-xM3+ x(OH)2](An-)x/ n·mH2O, wherein M2+(M3+), An-, x, m are respectively divalence or trivalent metal cation, interlayer anion, M3+/(M2++M3+) rub Your when crystallization water quantity.The structure of such material is by positively charged class shepardite layer and the exchangeable anions and moisture of interlayer Son is formed.Strong covalent bond effect in LDHs laminates be present, interlayer then has a kind of weak interaction force, i.e. interlayer object anion It is connected between main layer board with weak chemical bonds such as electrostatic attraction, hydrogen bond or Van der Waals forces, and main, object is all in an orderly way Arrangement form supramolecular structure (compound) compound.Interlayer, which introduces new object anion, can make layer structure and composition produce phase The change answered, many organic intercalation hydrotalcite materials with specific function or structure novelty are prepared, extensively should Used in the field such as catalysis, absorption, medicine, photoelectricity, environmental protection and agricultural chemicals.
In controlled drug delivery system, except medicine in itself in addition to, pharmaceutical carrier plays key player.Current medicine carries Body is mostly that research of the developed country such as high polymer material, America and Europe to slow/controlled release material is very active, especially with regard to can biology drop The research of solution property polymeric material turns into current research emphasis and development trend.It is but this with specific function polymer Preparation difficulty is larger, and cost is higher.Therefore, at present to the pharmaceutical dosage form transformation also progress of not making a breakthrough property.In recent years, including Inorganic material including mesoporous material, stratified material replaces polymeric material to be used for the carrier of medicine slow/controlled release system increasingly It is valued by people.
Supermolecular intercalation structure slow/controlled release drug system integrates the advantage of LDHs carriers and polymer support, can be more To be accurately controlled release of the oral slow/controlled release medicine in gastrointestinal region.
The limitation that medicine uses, it is small etc. to be not only present in poorly efficient and therapeutic domain, be more present in can not gram In terms of the toxic side effect of clothes.Control delivery for reduce drug dose, the control medicine zone of action, improve medicine action potency, Reduce toxic side effect etc., undoubtedly a kind of very effective approach.Supermolecular intercalation structure slow/controlled release drug system is ground The development of slow/controlled release preparation can be promoted in terms of practical application by studying carefully, and the exploitation of development and use of approved drugs for nonapproved uses for new drug provides more For wide application prospect;It can further promote the development of supermolecular intercalation chemistry even supramolecular chemistry in theoretical side.
Citric acid obtains a wide range of applications in field of medicaments.JairoTnirto is introduced citrate with coprecipitation LDHs interlayers prepare intercalation configuration LDHs as sustained release sex medicine, show good application effect.But coprecipitation is not only Experiment condition is harsh, and course of reaction needs N2Protection, and precipitation process citrate can form complex compound with Mg and Al so that Intercalation assembling becomes very difficult, and obtained intercalation product crystallinity is low, and crystal structure is imperfect, is not easy to obtain complete intercalation Product.
The content of the invention
To achieve the above object, the present invention provides a kind of citric acid pillared hydrotalcite supramolecular materials, energy control release, tool There is slow releasing function;Solve in the prior art that citric acid effect is low, therapeutic domain is small, the zone of action is uncontrollable, can not overcome The problem of toxic side effect.
It is another object of the invention to provide a kind of intercalation assemble method of citric acid pillared hydrotalcite.
The technical solution adopted in the present invention is a kind of citric acid pillared hydrotalcite supramolecular materials, and chemical molecular formula is: Mg6Al2(OH)15C6H5O7
A kind of intercalation assemble method of citric acid pillared hydrotalcite supramolecular materials, is specifically followed the steps below:
Step 1:Magnalium LDHs is prepared using nucleation/crystallization isolation method:Weigh 6.4g NaOH and 1.1g anhydrous Nas2CO3Add Enter proportionaling alkali-forming solution A in 60ml deionized waters to be put into 500ml beakers;The another MgSO for taking 14.8g4·7H2O、13.3gAl2 (SO4)3·18H2O is added in 80ml deionized waters and is made into salting liquid B;B solution is added in solution A under fierce magnetic agitation, Then it is heat-treated 20h in 62-66 DEG C of water;PH value is washed to less than 8,70 DEG C of oven drying 18h are put into after centrifugation, are obtained Magnalium LDHs;
Step 2:4.5g magnaliums LDHs made from step 1 method is added in the beaker for filling 100mL deionized waters, room The lower magnetic agitation of temperature, excessive citric acid 7.5g is added until turbid solution is changed into settled solution in beaker, it is standby;
Step 3:CO is eliminated with 100mL2Deionized water dissolving 2gNaOH, be subsequently poured into there-necked flask, magnetic agitation While, the settled solution that step 2 obtains is added dropwise, pH is kept during dropwise addition>9, pH is adjusted with NaOH, until in settled solution Precipitation is engendered, after completion of dropwise addition, oil bath heating backflow 6h, is fully washed to pH with 40-50 DEG C of hot water<8, centrifuge The obtained pillared LDHs of citric acid produces in 75 DEG C of dry 14h.
The invention has the advantages that the present invention has advantages below:
(1) present invention is with CO3 2Magnalium hydrotalcite is precursor, and the intercalation assembling chemical reaction carried out with the back-mixing precipitation method can Obtain the pillared LDHs of supramolecular structure citric acid.
(2) the pillared LDHs interlamellar spacings of citric acid are 1.25nm, and citrate is that with two there is symmetrical carboxyl to be mutually one Determine a slab effect of angle and hydrotalcite, and another carboxyl relies on ionic bond perpendicular to another laminate of hydrotalcite Function.
(3) citrate ion enters hydrotalcite layers, and intercalation assembling improves the heat endurance of citric acid, decomposes temperature Degree is 439 DEG C.
(4) the pillared LDHs supramolecular structures medicine sustained release agent of citric acid is prepared by the back-mixing precipitation method, can controls and release Put, there is slow releasing function.
The course of reaction of the intercalation assemble method of citric acid pillared hydrotalcite of the present invention does not need N2Protection, citric acid are pillared The intercalation assemble method of hydrotalcite is simple, and obtained citric acid pillared hydrotalcite passes through X-ray powder diffraction (XRD), infrared light Spectrum analysis (IR), three kinds of methods of differential thermal analysis (DTA) are characterized and surveyed to its crystal structure, chemical constitution and heat endurance It is fixed;Citric acid is in interfloor height ordered arrangement, crystal formation is complete, without dephasign, can obtain the product of complete intercalation;Interfloor distance Expanding, i.e., intercalation assembles successfully citric acid, and with individual layer, perpendicular acting in interlayer;Citric acid pillared hydrotalcite Drug release rate determines under the conditions of pH3.6 acetate buffer, the results showed that citric acid pillared hydrotalcite rate of release drops It is low, there is slow releasing function, illustrate that citric acid-inorganic mixture material can act as effective drug delivery system.
Brief description of the drawings
In order to illustrate more clearly about the embodiment of the present invention or technical scheme of the prior art, below will be to embodiment or existing There is the required accompanying drawing used in technology description to be briefly described, it should be apparent that, drawings in the following description are only this Some embodiments of invention, for those of ordinary skill in the art, on the premise of not paying creative work, can be with Other accompanying drawings are obtained according to these accompanying drawings.
Fig. 1 is magnalium LDHs XRD spectra.
Fig. 2 is the pillared LDHs of citric acid XRD spectra.
Fig. 3 is magnalium LDHs IR spectrograms.
Fig. 4 is the pillared LDHs of citric acid IR spectrograms.
Fig. 5 is the pillared LDHs of citric acid DTA curve.
Fig. 6 is magnalium LDHs DTA curve.
Fig. 7 is the supramolecular structure model schematic of citric acid pillared hydrotalcite prepared by the back-mixing precipitation method.
Fig. 8 is that the pillared LDHs of citric acid, citric acid+LDHs physical mixture, citric acid are molten in pH3.6 acetate salt buffers Releasing curve diagram in liquid.
Embodiment
Below in conjunction with the accompanying drawing in the embodiment of the present invention, the technical scheme in the embodiment of the present invention is carried out clear, complete Site preparation describes, it is clear that described embodiment is only part of the embodiment of the present invention, rather than whole embodiments.It is based on Embodiment in the present invention, those of ordinary skill in the art are obtained every other under the premise of creative work is not made Embodiment, belong to the scope of protection of the invention.
Material and instrument:
MgSO4·7H2O (Shantou, Guangdong city Xi Long chemical plant), Al2(SO4)3·18H2O (Tianjin Ke Miou chemical reagent Development centre), NaOH (Tianjin Ke Miou chemical reagent development centre), anhydrous Na2CO3, (Tianjin section is close europeanized for citric acid Learn reagent development centre), copper sulphate (Yantai three and chemical reagent Co., Ltd), acetic acid (Shanghai Nuo Tai Chemical Co., Ltd.s), Sodium acetate (Langfang Asia-Pacific Long Xing Chemical Co., Ltd.s).
Infrared spectrum is determined with AVATAR360 (Nicolet companies of the U.S.) type FTIS, KBr pressures Piece.
Differential thermal (DTA) analysis of sample is combined in Chemistry and Chemical Engineering College of Central South University and Hunan Bo Di Electric Applicance Co., Ltd grinds Carried out on the differential thermal analysis system of system, heating rate is 10 DEG C/min, is operated in air atmosphere.
Thermogravimetric (TG) analysis of sample is carried out on WRT-3P types micro thermal balance (Shanghai balance factory).
X-ray powder diffraction determines on the x ray diffractometer xs of D-MAX 2500 (Rigaku company), CuK α 1.
UV scanning and absorbance determine on UV-3802 types ultraviolet-uisible spectrophotometer (Shanghai analytical instrument factory).
Drug dissolution determines on RCZ-6B drug dissolutions instrument (Shanghai Huanghai Sea medicine inspection Instrument Ltd.).
Drug dissolution determines on RCZ-6B drug dissolution instrument.
Magnalium LDHs (Mg-Al-CO3- LDHs) preparation:
Magnalium LDHs precursors are prepared using nucleation/crystallization isolation method:Weigh 6.4g NaOH and 1.1g anhydrous Nas2CO3Add Proportionaling alkali-forming solution A is put into 500ml cups in 60ml deionized waters;The another MgSO for taking 14.8g4·7H2O、13.3gAl2(SO4)3· 18H2O adds 80ml deionized waters and is made into salting liquid B;B solution is added in solution A under fierce magnetic agitation, then in 62- 20h is heat-treated in 66 DEG C of water;PH value is washed to less than 8,70 DEG C of oven drying 18h are put into after centrifugation, obtain magnalium LDHs.
The back-mixing precipitation method prepare the pillared LDHs of citric acid (hydrotalcite):
4.5g magnalium LDHs is added in the beaker for filling 100mL deionized waters, magnetic agitation, was added at room temperature Amount citric acid 7.5g until beaker in turbid solution be changed into settled solution, it is standby;CO is eliminated with 100mL2Deionized water dissolving 2gNaOH, it is subsequently poured into there-necked flask, while magnetic agitation, the settled solution that step 2 obtains is added dropwise, is kept during dropwise addition pH>9, pH is adjusted with NaOH, until engendering precipitation in settled solution;After completion of dropwise addition, oil bath heating backflow 6h, 40- is used 50 DEG C of hot water is fully washed to pH<8, the pillared LDHs of citric acid being centrifugally separating to obtain produce in 75 DEG C of dry 14h.
Vitro release determines:
(1) wavelength selects:
Precision weigh dry to constant weight Acidum Citricum sodium and appropriate copper sulphate, respectively using pH3.6 acetate buffer as Medium, the copper-bath for being configured to 1826 μ g/ml Acidum Citricums sodium solutions and 1323 μ g/ml are standby.Precision measures Acidum Citricum sodium Solution 3ml is put in l00ml volumetric flasks, is added copper-bath 5ml, is added pH3.6 acetate buffer to be shaken up to scale, put Put 5min.Copper-bath 5ml separately is taken in l00ml volumetric flasks, adds pH3.6 acetate buffer to shake up, place to scale 5min, as blank, scanned in 200-350nm wave-length coverages, measure a length of 240 ± 0.5nm of maximum absorption wave.
(2) standard curve:
Precision measures sodium citrate solution 2ml, 2.5ml, 3ml, 3.5ml, 4ml, 4.5ml and put respectively in 100ml volumetric flasks, Add copper-bath 5ml;PH3.6 acetate buffers are added to be surveyed to the scale of volumetric flask according to maximum absorption wavelength determination method Determine trap.5ml copper-baths are taken, add pH3.6 acetate buffers into 100ml volumetric flasks, as blank.It is in wavelength Trap is determined at 240 ± 0.5nm, with A2With C (ug/m1) return regression equation is:
A2=-0.11977+0.00792C, r=0.9999, (n=6) wherein, A is absorbance, and C is solution concentration;
As a result show, sodium citrate concentration A in the range of 40~80 μ g/ml2It is good with C linear relationships.
(3) drug release determination:
By version in 2005《Chinese Pharmacopoeia (two)》The methods of annex XC first, using pH3.6 acetate buffers 900mL as dissolution Medium, 37 ± 0.5 DEG C of temperature, rotating speed 50r/min, samples take solution 8ml respectively at regular intervals, with 0.8 μm of miillpore filter Filtration, and distilled water 8ml is supplemented in process container in time.Primary filtrate is discarded, precision measures subsequent filtrate 2ml, puts 50ml capacity In bottle, after adding copper-bath 3ml, add pH3.6 acetate buffer constant volume, stand 5min.According to UV-vis spectroscopy light Degree method, see version in 2005《Chinese Pharmacopoeia (two)》The A of annex IV), at 240 ± 0.5nm wavelength, after diluting identical multiple Copper-bath makees blank, surveys its absorbance with ultraviolet-visible spectrophotometer, calculates the cumulative release amount of citric acid.Sampling Time:Citric acid, citric acid+LDHs physical mixture are 1min, 3min, 10min, 40min, 80min, 100min;Lemon The pillared LDHs of acid is 5min, 10min, 15min, 20min, 30min, 40min, 60min, 80min, 100min.
XRD analysis:
From Fig. 1-2 and table 1 as can be seen that the pillared LDHs of citric acid synthesized with the inventive method characteristic diffraction peak all to Low-angle moves, and the characteristic diffraction peak for representing interfloor height is 003, and 2 θ are reduced to 7.0 ° by 11.5 °, correspondence interlamellar spacing by 0.76nm is increased to 1.25nm, because shepardite laminate thickness is 0.48nm, interlamellar spacing subtracts laminate thickness and obtains citric acid post Interlayer object is highly 0.77nm after support.Illustrate that intercalation enters hydrotalcite layers to citrate ion, passes through carboxylic in interlayer Base is connected with laminate, and individual layer, perpendicular acting are in interlayer.
The magnalium LDHs of the table 1 and pillared LDHs of citric acid XRD diffraction peak datas
Fig. 3 is in 3448cm-1Place is OH in magnalium LDHs-Stretching band, in 3448cm-1Locating wider bands of a spectrum is The stretching band of-the OH of physical absorption water or crystallization water vibrational bands and M-OH, in addition in 1637cm-1Also there is the weak of water at place Flexural vibrations bands of a spectrum.1363cm-1Left and right is CO3 2-Symmetric vibration bands of a spectrum, in 1040~1100cm-1With 780~890cm-1Place It is CO3 2-Weak stretching band outside in face and face;Less than 1000cm-1Other bands of a spectrum be M-O vibrational bands.
As seen from Figure 4,3450cm-1The absworption peak at place belongs to the stretching vibration of OH- in the pillared LDHs of citric acid, with 3600cm-1Free state-the OH at place is compared, and between interlayer anion and/or laminate hydroxyl hydrogen may occur for interlayer hydrone Key acts on, thus this peak is to lower wave number displacement.
After the pillared LDHs of citric acid, CO3 2-Absworption peak disappears;1637cm-1There is the absworption peak of the last one at place, belongs to the crystallization water - OH vibration, due to containing a molecular water in citric acid molecule, make to contain more water in the pillared LDHs of citric acid, thus this Corresponding peak intensity of the peak compared with magnalium LDHs in Fig. 3;Due to containing three carboxyls in citric acid molecule, in 1400cm-1Place occurs strong The asymmetric absworption peak of carboxylic acid ion.
Fig. 3 and Fig. 4 IR spectrograms illustrate that citric acid instead of the CO in magnalium LDHs3 2-, realize the pillared LDHs of citric acid The intercalation assembling of Supramolecular layered material.
The pillared LDHs of citric acid heat endurance:
Fig. 5 is the pillared LDHs of citric acid DTA curve, occurs endothermic peak mainly absorption and intermediary water at 100~200 DEG C Removing;Occurs obviously exothermic peak at 400~500 DEG C, the summit temperature of corresponding exothermic peak is about 439 DEG C, and this is main It is that organic matter (citric acid) aoxidizes caused by (burning) in atmosphere.
Compare Fig. 5 and Fig. 6 to understand:There is no exothermic peak on magnalium LDHs DTA curve, and occur after inserting citric acid bright Aobvious exothermic peak, illustrate that citrate enters hydrotalcite layers.
The decomposition temperature of citric acid is between 160~250 DEG C.After citrate pillared hydrotalcite, the decomposition temperature of citric acid Degree is 400~500 DEG C by 160~207 DEG C of rises, after illustrating that citrate enters LDHs interlayers, due to interlayer object citric acid Interaction between root and main body LDHs laminates be present, the heat endurance of citric acid is improved.
XRD, IR, DTA characterization result explanation are reacted assembling by intercalation chemistry and obtained by main body (LDHs), object (lemon Acid) a variety of primitives composition pillared hydrotalcite, a variety of of bondings such as ionic bond and main layer board covalent bond between main body, object, visitor Supramolecular layered material of the body in interfloor height ordered arrangement.
The pillared LDHs of citric acid supramolecular structure, as shown in fig. 7, citrate has 3 carboxyls, 2 carboxyls therein With certain symmetry, and citrate is to be present in hydrotalcite layers in the form of negative trivalent anion, so citric acid Root should have the mutual angled and slab effect of hydrotalcite of symmetrical carboxyl with two.And another carboxyl Another laminate perpendicular to hydrotalcite functions by ionic bond, and such arrangement is just most stable and meets what experiment obtained Interlamellar spacing numerical value.It is 1.25nm by the interlamellar spacing being calculated of XRD spectrum, it is contemplated that laminate height (thickness) degree has 0.48nm, lemon Lemon acid molecule should be 0.77nm in the height of interlayer, due to there is 0.27nm hydrogen bond region between Subjective and Objective, so citrate Numerical value after the real height of interlayer should be removing hydrogen bond region distance, i.e. 0.50nm.
As shown in figure 8, citric acid+LDHs physical mixture, citric acid, it is impossible to control release, without slow releasing function, Just discharged in 4min completely.And the pillared LDHs energy control release of citric acid, there is slow releasing function, 89% is discharged in 20min, 100min is needed just to discharge completely.Releasing Mechanisms of the pillared LDHs of citric acid in acetate buffer solution is the acetic acid in solution The Citrate anions of radical ion and the pillared LDHs interlayers of citric acid swap, and acetate ion enters LDHs interlayers, and lemon Lemon acid anion enters solution, and the incipient stage, ion-exchange speed is very fast, with the progress of ion exchange, ion-exchange speed Progressively increase, after reaching maximum, with the progress of ion exchange, ion-exchange speed gradually reduces again.
The foregoing is merely illustrative of the preferred embodiments of the present invention, is not intended to limit the scope of the present invention.It is all Any modification, equivalent substitution and improvements made within the spirit and principles in the present invention etc., are all contained in protection scope of the present invention It is interior.

Claims (1)

1. a kind of intercalation assemble method of citric acid pillared hydrotalcite supramolecular materials, it is characterised in that specifically according to following step It is rapid to carry out:
Step 1:Magnalium LDHs is prepared using nucleation/crystallization isolation method:Weigh 6.4g NaOH and 1.1g anhydrous Nas2CO3Add Proportionaling alkali-forming solution A is put into 500ml beakers in 60ml deionized waters;The another MgSO for taking 14.8g4·7H2O、13.3gAl2 (SO4)3·18H2O is added in 80ml deionized waters and is made into salting liquid B;B solution is added in solution A under fierce magnetic agitation, Then it is heat-treated 20h in 62-66 DEG C of water;PH value is washed to less than 8,70 DEG C of oven drying 18h are put into after centrifugation, are obtained Magnalium LDHs;
Step 2:4.5g magnaliums LDHs made from step 1 method is added in the beaker for filling 100mL deionized waters, at room temperature Magnetic agitation, add excessive citric acid 7.5g until beaker in turbid solution be changed into settled solution, it is standby;
Step 3:CO is eliminated with 100mL2Deionized water dissolving 2gNaOH, be subsequently poured into there-necked flask, magnetic agitation it is same When, the settled solution that step 2 obtains is added dropwise, pH is kept during dropwise addition>9, pH is adjusted with NaOH, until in settled solution gradually Precipitate, after completion of dropwise addition, oil bath heating backflow 6h, fully washed to pH with 40-50 DEG C of hot water<8, it is centrifugally separating to obtain The pillared LDHs of citric acid in 75 DEG C of dry 14h, produce;
The chemical molecular formula of obtained citric acid pillared hydrotalcite supramolecular materials is:Mg6Al2(OH)15C6H5O7
CN201610368501.4A 2016-05-30 2016-05-30 Citric acid pillared hydrotalcite supramolecular materials and its intercalation assemble method Expired - Fee Related CN105948086B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610368501.4A CN105948086B (en) 2016-05-30 2016-05-30 Citric acid pillared hydrotalcite supramolecular materials and its intercalation assemble method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610368501.4A CN105948086B (en) 2016-05-30 2016-05-30 Citric acid pillared hydrotalcite supramolecular materials and its intercalation assemble method

Publications (2)

Publication Number Publication Date
CN105948086A CN105948086A (en) 2016-09-21
CN105948086B true CN105948086B (en) 2018-01-30

Family

ID=56910992

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610368501.4A Expired - Fee Related CN105948086B (en) 2016-05-30 2016-05-30 Citric acid pillared hydrotalcite supramolecular materials and its intercalation assemble method

Country Status (1)

Country Link
CN (1) CN105948086B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108517561B (en) * 2018-03-30 2019-10-29 岭南师范学院 A kind of layered double hydroxide LDH-Cl3The preparation method and applications of-I whisker
CN109502656B (en) * 2018-11-29 2021-02-19 兰州金通储能动力新材料有限公司 Spherical Co (II) Co (III) hydrotalcite-like material and preparation method thereof
CN112080263B (en) * 2020-09-21 2022-05-20 西南石油大学 Preparation method of slow-release retarder for well cementation

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1467177A (en) * 2002-06-24 2004-01-14 北京化工大学 Method for assembling anion type supramolecular intercalation structure material
CN1769182A (en) * 2005-09-05 2006-05-10 北京化工大学 Metal sulfide semiconductor nanometer composite material using hydrotalcite as model and its preparation method

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1467177A (en) * 2002-06-24 2004-01-14 北京化工大学 Method for assembling anion type supramolecular intercalation structure material
CN1769182A (en) * 2005-09-05 2006-05-10 北京化工大学 Metal sulfide semiconductor nanometer composite material using hydrotalcite as model and its preparation method

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
L -(-)-酒石酸柱撑水滑石的插层组装及超分子结构;彭霞辉等;《长沙大学学报》;20050930;第19卷(第5期);第36-39页 *
L-天冬酸插层水滑石的组装及其结构表征;彭霞辉等;《材料导报》;20051231;第19卷(第12期);第113-116页 *
柠檬酸柱撑水滑石的制备及结构表征;王剑峰;《四川理工学院学报》;20090228;第22卷(第1期);第68-71页 *
返混沉淀法制备超分子结构阴离子插层LDHs研究;张杰;《万方数据》;20041021;第20-21页 *

Also Published As

Publication number Publication date
CN105948086A (en) 2016-09-21

Similar Documents

Publication Publication Date Title
Tokumoto et al. Catalysis and temperature dependence on the formation of ZnO nanoparticles and of zinc acetate derivatives prepared by the sol− gel route
JP4964585B2 (en) Ferric organic compounds, their use, and methods for their production
US9079774B2 (en) Inorganic material made of spherical particles of specific size and having metallic nanoparticles trapped in a mesostructured matrix
Mannaa et al. MCM-41 grafted with citric acid: The role of carboxylic groups in enhancing the synthesis of xanthenes and removal of heavy metal ions
CN103350000B (en) Metal-organic framework/SiO2 composite nanomaterial with core/shell structure and preparation method and application thereof
CN105948086B (en) Citric acid pillared hydrotalcite supramolecular materials and its intercalation assemble method
US20210108001A1 (en) Nanocrystalline cellulose, its preparation and uses of such nanocrystalline cellulose
Blinov et al. Synthesis of multicomponent systems based on silicon dioxide and noble metal nanoparticles
Ahirwar et al. Synthesis of mesoporous TiO 2 and its role as a photocatalyst in degradation of indigo carmine dye
Wu et al. Effects of acid ionization on the formation mechanism of bimodal mesoporous Al-MCM-41s from coal gasification fine residue and evaluation of adsorption capabilities
CN101172628B (en) Method of producing nano MgO/Mg(OH)* composite powder body
CN113385148A (en) Framework material with Ag nano-particle compound, preparation method and application
Latifi et al. Rice-like Ag/Al 2 O 3 nanocomposites preparation from AlOOH nanostructures synthesized via a facile hydrothermal route for azo dyes photocatalytic degradation and Pb 2+ adsorption
CN111217372B (en) Chiral mesoporous core-shell structure silica nanoparticle and preparation method and application thereof
Ali et al. Silver nanoparticles@ titanate nanotubes composite: synthesis, characterization, applications and docking
Sabeena et al. Comparative synthesis and characterization of nanocomposites using chemical and green approaches including a comparison study on in vivo and in vitro biological properties
Ejeromedoghene et al. Reroute green synthesis of hexagonal and triclinic nanostructured cerium oxide: morphology and optical properties
CN109046231B (en) Method for preparing mesoporous copper bismuth silicate nano composite material by ultrasonic-assisted hydrothermal synthesis method and application
CN1212330C (en) Medicinal complex dibaicalin zinc and its preparation method
Akhbari et al. The effects of solvent and ultrasonic irradiation in synthesis of thallium (I) nano supramolecular polymers and use them as template for synthesis of thallium (III) oxide nanostructures with desirable morphology
Abdolyousefi et al. Fabrication of 5-fluorouracil loaded multi-responsive molecularly imprinted poly (NVCL-co-MAA) coated black titanium dioxide nanocomposite as a chemo-photodynamic therapy agent
JP2005289660A (en) Surface-modified titanium dioxide particulate and dispersion thereof and method for manufacturing the same
CN109305988A (en) Ciprofloxacin metal complex and its preparation method and application
Prihatiningsih et al. Rifampicin adsorption and release study using Santa Barbara amorphous-16 modified Al (SBA-16-Al) for a drug delivery system
Chang et al. Application of thermal alkaline hydrolysis technology to improve the loading and in-vitro release of gallic acid in UiO-66

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20180130

Termination date: 20180530

CF01 Termination of patent right due to non-payment of annual fee